Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.
about
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of CardiologyMECHANISMS UNDERLYING ACTION OF XINMAILONG INJECTION, A TRADITIONAL CHINESE MEDICINE IN CARDIAC FUNCTION IMPROVEMENT.The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the ratThe myosin activator omecamtiv mecarbil: a promising new inotropic agent.Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro.
P2860
Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.
@en
type
label
Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.
@en
prefLabel
Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.
@en
P2093
P2860
P921
P1476
Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.
@en
P2093
László Nagy
Piero Pollesello
Zoltán Papp
P2860
P304
P356
10.1097/FJC.0000000000000113
P577
2014-09-01T00:00:00Z